Mette Kristin Lund • 1959 • Greåker • 10 roles • 9 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Boards

Name	Role	Total operating income	Total equity	Shares
P PHARMAPAC AS	Board Member	-	12,499	50 % directly
V VITAMAX AS	Board Member	-	2,971,981	50 % indirectly
B BIOPHARMA AS	Board Member	33,712,688	8,597,842	40.31 % indirectly
P PHARMATECH AS	Alternate Member	505,693,040	51,016,002	40.31 % indirectly
B BIOSAN AS	Alternate Member	9,045,079	10,845,174	40.31 % indirectly
G GME LUND HOLDING AS	Chairman	-	29,094,487	40.31 % directly
M MULTILAB ØSTFOLD AS	Alternate Member	5,032,020	2,119,041	40.31 % indirectly
F FARMATEKET AS	Alternate Member	122,516	451,068	40.31 % indirectly
B BIO-SAN ANS	Participant with Joint and Several Liability (Full Responsibility)	-	-	-
L LAVENDULA ANS	Participant with Joint and Several Liability (Full Responsibility)	-	-	-

Last update: Apr 13, 2023

Related industries2

Direct relationships4

Shares owned by Mette Kristin Lund

Name	Share class	Total operating income	Total equity	Share
P PHARMAPAC AS	Ordinære aksjer	0	12,499	50 % directly
V VITAMAX AS		0	2,971,981	50 % indirectly
G GME LUND HOLDING AS	Ordinære aksjer	0	29,094,487	40.31 % directly
B BIOPHARMA AS		33,712,688	8,597,842	40.31 % indirectly
P PHARMATECH AS		505,693,040	51,016,002	40.31 % indirectly
B BIOSAN AS		9,045,079	10,845,174	40.31 % indirectly
M MULTILAB ØSTFOLD AS		5,032,020	2,119,041	40.31 % indirectly
F FARMATEKET AS		122,516	451,068	40.31 % indirectly
L LUND EIENDOM FREDRIKSTAD AS		7,636,958	19,805,414	40.31 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025